Skip to main content
. 2018 Jan 5;22(3):1840–1854. doi: 10.1111/jcmm.13468

Figure 6.

Figure 6

Neurogenic differentiative ability of CLP‐CMCs is demonstrated in vitro. (A) qPCR analysis of ß‐tubulin isotype III/TUBB3, synaptophysin/SYP and neuronal nuclear antigen RBFOX3/NEUN). (B) Immunofluorescence detection of TUBB3. Nuclei were counterstained with Fluoro‐Gel II solution containing DAPI. Scale bar: 10 μm.